Finally, based on previous studies, the P2X7 receptor can be considered a potential pharmacological target for counteracting Alzheimer's disease progression, and Quercetin emerges as a promising flavonoid with neuroprotective properties. This evidence concerns the gene P2RX7 and early-onset autosomal dominant Alzheimer disease.